Hospital
Medcentral Health System
Medcentral Health System was paid $3.13M by Medicaid between Jan 2018 and Dec 2024, across 86 billing codes. Its largest line is 99283, emergency room visit (moderate) — 36% of everything it billed.
33Billing provider infoMEDCENTRAL HEALTH SYSTEM
MANSFIELD, OH 44903
MANSFIELD, OH 44903
33aNPI1487706016assigned 01/16/2007
33bProvider typeCritical Access Hospital
28Total paid$3.13M
24GClaims63,302
24DCodes billed86
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Ohio
Rank by total paid#22 of 26
Median peer was paid$5.33M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BROWNING, MICHAEL controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,284 | $197K | |
| 2019 | 4,801 | $176K | |
| 2020 | 3,994 | $241K | |
| 2021 | 5,316 | $263K | |
| 2022 | 6,487 | $323K | |
| 2023 | 23,690 | $1.09M | |
| 2024incomplete | 14,730 | $839K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 9,078 | 8,284 | $1.12M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 3,564 | 3,148 | $487K |
| 96361 | Intravenous infusion, hydration; each additional hour | 12% | 1,024 | 714 | $378K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.2% | 2,249 | 2,000 | $257K |
| 0240U | 4.5% | 926 | 787 | $139K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.8% | 900 | 726 | $120K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.2% | 434 | 360 | $101K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.2% | 1,308 | 300 | $100K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.1% | 435 | 350 | $98K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.7% | 328 | 272 | $86K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 543 | 338 | $46K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.1% | 120 | 100 | $35K |
74 more codes
| 80053 | Comprehensive metabolic panel | <1% | 4,262 | $24K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 125 | $20K |
| 73130 | <1% | 230 | $18K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 135 | $16K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,423 | $10K |
| 73110 | <1% | 101 | $9K | |
| J3490 | Unclassified drugs | <1% | 374 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 252 | $6K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,675 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 958 | $6K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 16 | $5K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 104 | $5K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 292 | $4K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,861 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 998 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 725 | $3K |
| 84484 | <1% | 1,646 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13 | $2K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 16 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 379 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,126 | $1K |
| 73630 | <1% | 103 | $1K | |
| 84703 | <1% | 747 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 165 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 330 | $1K |
| 73030 | <1% | 31 | $1K | |
| 81001 | <1% | 2,780 | $853.32 | |
| 73610 | <1% | 28 | $592.95 | |
| 82248 | <1% | 2,866 | $577.07 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $491.43 |
| 83880 | <1% | 307 | $438.64 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 304 | $388.17 |
| 87077 | <1% | 18 | $309.94 | |
| 80076 | <1% | 12 | $252.36 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 994 | $249.72 |
| 80061 | Lipid panel | <1% | 78 | $234.50 |
| 36591 | <1% | 29 | $230.51 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 360 | $222.92 |
| 83690 | <1% | 1,075 | $131.84 | |
| 84702 | <1% | 77 | $129.35 | |
| 85610 | <1% | 194 | $126.27 | |
| 97162 | <1% | 12 | $124.51 | |
| 82077 | <1% | 70 | $103.77 | |
| 83605 | <1% | 411 | $63.85 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 18 | $63.28 |
| 83735 | <1% | 74 | $58.07 | |
| 80051 | <1% | 48 | $47.17 | |
| 82565 | <1% | 60 | $45.03 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,420 | $43.53 |
| 85379 | <1% | 265 | $34.70 | |
| 82947 | <1% | 48 | $25.60 | |
| 81003 | <1% | 502 | $21.33 | |
| 87186 | <1% | 17 | $13.80 | |
| 84520 | <1% | 48 | $13.32 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 88 | $11.80 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 674 | $11.63 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 237 | $8.09 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 931 | $6.68 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 326 | $2.30 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $1.93 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 178 | $0.62 |
| 82803 | 0% | 196 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 150 | $0.00 |
| 87040 | 0% | 56 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 158 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 30 | $0.00 |
| 87081 | 0% | 29 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 13 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 781 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 55 | $0.00 |
| 85014 | 0% | 219 | $0.00 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 14 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 14 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBROWNING, MICHAEL (CFO, OHIOHEALTH)
Parent organizationOHIO HEALTH CORPORATION
| Provider | Location | Paid |
|---|---|---|
| Ohiohealth Corporation | Columbus, OH | $214.99M |
| Ohiohealth Corporation | Columbus, OH | $76.95M |
| Ohiohealth Corporation | Columbus, OH | $72.29M |
| Ohiohealth Corporation | Columbus, OH | $44.08M |
| Medcentral Health System | Mansfield, OH | $36.92M |
| Marion General Hospital, INC. | Marion, OH | $36.47M |
| Sheltering Arms Hospital Foundation, INC. | Athens, OH | $26.88M |
| Ohiohealth Berger Hospital LLC | Circleville, OH | $16.38M |
| Ohiohealth Corporation | Dublin, OH | $11.81M |
| Grady Memorial Hospital | Delaware, OH | $9.51M |
| Hardin Memorial Hospital | Kenton, OH | $7.27M |
| Madison Family Health Corporation | London, OH | $1.03M |
| Marion General Hospital, INC. | Marion, OH | $683K |
| Medcentral Health System | Mansfield, OH | $477K |
| Sheltering Arms Hospital Foundation | Athens, OH | $435K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.